The Better Regulation agenda is a key determinant of how policies affecting health are conceived, designed, adopted, implemented, evaluated and revised within the European Union (EU) policy process. As such, it should be a crucial component of the advocacy, campaigning and strategy of civil society organisations seeking to promote health in Europe. This toolkit, developed as part of the Better Regulation for Better Health project, is designed to support consideration of and engagement with Better Regulation by civil society organisations interested in health and other social issues. It offers an introduction to what Better Regulation is and how it works, an argument for how and why Better Regulation matters to public health, and a variety of resources to support engagement and learn more.
Introducing Better Regulation
The Better Regulation agenda is a “good governance” programme designed to ensure the quality of legislative output in the EU via a range of tools and activities, including mandatory impact assessment, stakeholder consultation and periodic review of the “fitness for purpose” of existing regulation. It shapes the policy process across all sectors, including health, and is therefore a core element of EU health governance.
The contemporary Better Regulation agenda, comprised of a toolbox and a set of guidelines to be utilised by officials in the three legislative institutions of the EU (European Commission, Council of the EU, and European Parliament) was adopted in 2015 by the Juncker Commission. However, the origins of the agenda reach much further back. The Single European Market project and ideas about the role of regulation in the European economy, the Subsidiarity Principle and concern about the appropriate exercise of EU law-making powers, and successive efforts to modernise and reform the organisation of the Commission, have all contributed to the objectives and instruments of Better Regulation as it is now known. Underpinning many of these influences is a set of wider neoliberal pressures that prioritise economic growth, competitiveness and the market, and frame regulation in relation to these priorities.
The Better Regulation programme has three objectives:
- Ensuring EU policy making is based on evidence
- Making EU laws simpler, and avoiding unnecessary burdens
- Involving citizens, businesses and stakeholders in the decision-making process, which relates therefore to civil society engagement in policy-making.
Less clear is the intended purpose that is served by pursuing these objectives. The term Better Regulation is poorly defined, in that there is no single explicit statement of how “better” should be understood or assessed, or what the rationale of the agenda is. Most often, the Commission defines Better Regulation as a “way of working” – one that involves legislating only where necessary, maximising benefits and minimising costs, professionalising policy-making – and emphasises what Better Regulation is not, generally citing deregulation or less regulation. The current guidelines state that Better Regulation “seeks to design and prepare EU policies and laws in such a way that they achieve their objectives in the most efficient way”.
More concretely, recent revisions of the framework have directed it to simplify EU law and reduce unnecessary burdens, remove obstacles and red tape that hinder investment, mainstream the Sustainable Development Goals in EU policy-making, implement the “do no significant harm” and “digital transformation” goals, and integrate strategic foresight in the policy process. In this sense, Better Regulation combines a narrow focus on efficiency and burden (reflecting its earlier, deregulatory origins) with a much wider and fuzzier set of purposes (connected to contemporary political priorities) without explicitly addressing their coherence. As such, the BRBH project has approached Better Regulation from two different angles:
- Firstly, as a regulatory tool and practical toolbox, which requires consultation of stakeholders and their involvement in policy-making;
- Secondly, an ideological agenda and narrative, supporting the delivery of EU political priorities.
Next, read our explainers on…The Better Regulation tools, and The Better Regulation narratives
Better Regulation tools
The current version of the Better Regulation agenda is presented in a 2021 Communication and detailed in two core documents:
- The Better Regulation Guidelines, which set out requirements for the key steps in the policy cycle; and
- The Better Regulation Toolbox, which provides practical, hands-on guidance and operational details.
When explaining how Better Regulation is put into practice, the Guidelines highlight three initiatives that are of particular importance:
- The Regulatory Fitness and Performance (REFIT) programme, which systematically reviews the “fitness for purpose” of existing EU law and searches for opportunities to simplify and reduce burden.
- The one-in-one-out (OIOO) approach, which requires that the Commission offset administrative burdens created in new regulation by reducing equivalent burdens elsewhere.
- The quantification of costs and benefits wherever “feasible, relevant and proportionate”.
The Guidelines identify five key instruments of Better Regulation:
- Forward planning and validation: Planning involves the advance arrangement of the timing and sequencing of initiatives, whilst validation is about gaining approval before substantive work begins. As regards the latter, the Better Regulation toolbox (tool #6) explains how initiatives are categorised to determine the appropriate level of political sign-off, based on their degree of political sensitivity and importance.
- Stakeholder consultation: Consultation is required for most impact assessments, and encouraged for most evaluations and fitness checks. The Better Regulation toolbox (tools #51 to #55) offers guidance on how to identify stakeholders, design a consultation strategy, conduct consultation activities, and analyse the resulting data.
- Evaluation and fitness checks: Evaluations (assessing one piece of legislation), and fitness checks (assessing groups of related legislation) are conducted ex post, to establish how existing legislation has performed. A key goal of the Better Regulation agenda is to use evaluations and fitness checks to inform the development of new initiatives, and to implement the REFIT programme by assessing the “fitness for purpose” of the existing acquis. Tools #45 to #50 explain when an evaluation is required, what criteria and questions might be used, and how to format the report.
- Impact assessment: Drawing on evidence (including that from evaluations), impact assessment is used to justify the necessity of a new initiative and establish how it can best meet its policy objectives. Impact assessment reports frame the policy problem and the possible solutions, identify the potential impacts of each solution, and describe how the eventual legislation will be monitored and evaluated. The Better Regulation toolbox offers extensive guidance on conducting an impact assessment (tools #7 to #17), identifying specific types of impacts, including health impacts (tools #18 to #37), and using different methodologies to analyse impacts (tools #56 to #69).
- Quality control: The above steps and processes are overseen by several groups of actors. Specialised Better Regulation Units exist within most DGs, to advise and support the development of initiatives. DG Secretariat General maintains a network of these Units and acts as the central guidance point on methodological issues and the overall implementation of Better Regulation across the Commission. It also chairs most interservice steering groups, which are an additional point of oversight and input into policy development. Finally, the Regulatory Scrutiny Board (RSB) is responsible for assessing the quality of all impact assessments and fitness checks, as well as selected evaluations. The procedures for obtaining RSB approval are outlined in the toolbox (tool #3), and include the conduct of “upstream meetings” to guide the development of the impact assessment. The Board’s mandate states that it does not comment on the substance of impact assessment, fitness checks or evaluations; rather, its role is to assess the quality of the analysis and adherence to the Better Regulation procedures. The RSB is also responsible for advising on the implementation of the Better Regulation agenda. The independence and expertise of the Board has been criticised by both civil society and industry stakeholders, and subject to review and recommendation from the EU Ombudsman.
Other Better Regulation tools:
- Mainstreaming the Sustainable Development Goals (SDGs): a further objective of Better Regulation is now to ensure that the SDGs are mainstreamed within the policy process. This involves specifically considering the impacts of policies upon relevant SDGs, via impact assessment and evaluation, and the Commission has created a KnowSDGs (knowledge base for the SDGs) platform to assist policy-makers in this process (see tool #19).
- Strategic foresight: the strategic foresight agenda encourages impact assessments and evaluations to account for “megatrends” and long-term scenarios when assessing the impact of (proposed) policies. Among the megatrends of relevance to EU policy-making, the Commission identifies shifting health challenges – specifically referencing unhealthy lifestyles, pollution, and infectious diseases – as well as climate change, demographic imbalances, governance and inequalities (see tool #20).
- The competitiveness and SME (small and medium enterprises) checks: since 2021, all impact assessments must systematically screen for specific impacts upon competitiveness and SMEs. This involves considering, to the extent relevant for a given initiative, impact upon cost/price, capacity to innovate, and international competitiveness, as well as conducting an “SME test” to identify and minimise negative impacts falling on SMEs (see tool #23).
Next, read our explainers on Better Regulation narratives, and Civil society participation in Better Regulation.
Better Regulation narratives
In addition to a set of tools, Better Regulation can be seen as a political agenda. In this sense, it is a narrative built around a particular regulatory philosophy, which shapes the political environment in which policies affecting health are developed. It does this directly, when used as a tool for implementing political priorities and agendas, and indirectly, by advancing a narrative of EU regulation and policy-making that “chills” the regulatory environment.
Whilst the tools of the programme (impact assessment, consultation, and more) are all individually political, the idea of a single coherent agenda was most clearly advanced by President Juncker in 2015. The Juncker presidency set out to establish a more political Commission, and Better Regulation was a central part of this goal. Substantively, the commitment to creating an EU that is “big on the big things, and small on the small things”, by focusing on a discrete set of priority projects and scaling back EU action in other areas, was translated into action using the various tools of Better Regulation.
Forward planning and political validation are used to identify initiatives supporting priority projects and exclude or restrict those addressing non-priority issues or not envisaged in the Commission’s work programme. The proportionality and added value of EU action are systematically examined within impact assessment processes, and the contribution to burden monitored via the Fit for Future Platform (previously the REFIT – regulatory fitness – Platform) and Have Your Say: Simplify! Portal (previously the Lighten the Load initiative). Its overarching objectives – evidence-based policy-making, burden reduction, and participation – should thus be understood in this context, as means to achieving the political goals of the Commission.
Due, in large part, to its origins in the neoliberal, market-driven reforms of the 1970s and 1980s, the dominant narrative of Better Regulation is a deregulatory one. It directs attention and action to obligations and economic cost, using language about red tape, regulatory burden and complexity. Though the policy documentation often opens with a statement of the importance of regulatory protections and the achievements of the EU in this regard, the substance of the agenda is not focused on the value of regulation, but on the need to measure, control and minimise its costs. Specific reforms – such as the introduction of the SME Envoy and the one-in-one-out principle – are undertaken in pursuit of economic-driven goals, with limited reference to social, health or environmental values. More fundamentally, the instruments and processes of Better Regulation are presented as technocratic; as objective, evidence-based, and insulated from political decision-making, ostensibly justifying a lack of transparency.
Instruments for civil society and stakeholder participation in Better Regulation
Better Regulation establishes four key points or opportunities for stakeholders to participate in policymaking:
1. The “call for evidence”, usually launched as part of the evaluation or impact assessment, and including a public consultation (OPC) that must be open to the public at large for a minimum of 12 weeks.
Less commonly utilised is the provision to offer feedback on the consultation strategy. Consultation strategies are required and guided by the Better Regulation toolbox, and set out the Commission’s plans for the OPC and various other consultation activities, such as conferences, focus groups, targeted surveys and workshops. In the call for evidence, consultation strategies must be open for feedback from stakeholders, providing a valuable opportunity to shape the later points of engagement available.
2. Feedback on legislative proposals, once agreed and published by the Commission, which are usually open for 8 weeks.
This feedback is generally unstructured, written input that can be submitted by stakeholders and the general public. It is required for the European Commission to forward a summary of the feedback received to the European Parliament and the Council of the EU.
3. Feedback on draft delegated acts, implementing acts, and measures subject to regulatory procedure with scrutiny, open for 4 weeks by default.
Feedback on legislative drafts and delegated/implementing acts is a pathway of engagement less commonly utilised by CSOs but it offers a crucial benefit over OPC input, in that it is usually unstructured. Feedback is entered into a “free text” box, rather than being based on a questionnaire or survey, giving greater freedom to convey information. For these exercises, the Commission is required to report on how feedback is accounted for via the comitology register.
4. Feedback on any existing EU law, via the Have Your Say: Simplify! Portal, which feeds into the Fit for Future high-level expert group.
Overall, the Have Your Say: Simplify! portal is perhaps the least well-known and well-utilised avenue of participation for civil society actors. Its purpose is to allow citizens to identify existing EU laws that are burdensome or problematic, making its relevance to civil society unclear, and framing it as a tool that advantages economic and commercial actors. However, the remit of the Fit for Future Platform – the high-level expert group which receives submissions from the portal and delivers opinions to the Commission – is broader than burden reduction. Have Your Say: Simplify! assists in “making EU laws more efficient and fit for future, while achieving the policy objectives”. Carefully used, there exists here an opportunity to use the portal as a tool for focusing attention on legislation that fails to achieve its (social/health) objectives, imposes too great a burden upon specific groups, or is in need of future-proofing in order to reach its goals.
Other consultation exercises are implemented, such as:
- Conferences and public hearings: large public events, generally open to anyone who wishes to register and attend, that are directed at conveying information about the initiative to a larger audience of stakeholders. They may involve Q&A sessions but are primarily about dissemination. They can take place in-person or online.
- Workshops and seminars: smaller events, generally “closed” (invitation-only), that are directed at gathering information about the initiative from a smaller audience of stakeholders. They are more interactive in style and can be in-person or online.
- Interviews and focus groups: in-person or web-based activities to which selected stakeholders and experts are invited, aimed at collecting views and information on specific aspects of an initiative.
- Bilateral and small group meetings: closed meetings with European Commission officials that organisations may attend (virtually or in-person) to exchange views on an initiative. Such meetings can be arranged or accepted by the European Commission.
Health in the Better Regulation agenda
How do Better Regulation processes affect health, specifically? In the below, we gather some examples of where health features in documents produced by Better Regulation, to illustrate why these are important for health. We focus here on the opinions of the Regulatory Scrutiny Board (RSB), which assesses impact assessments and evaluations. These opinions are addressed to the Commission, which must respond to them in order to progress the initiative.
Example 1: the Audio-visual Media Services Directive
The RSB opinion on the impact assessment accompanying the revision of the Audiovisual Media Services Directive (AVMSD) in April 2016 highlights weaknesses in the impact assessment, which had been revised once already by Commission officials. It notes that:
“The streamlined problem description left behind some of the issues identified in the evaluation: this applies to the contentious ‘TV-like’ requirement for assessing the applicability of the AVMSD and consumer protection issues linked to the advertising of HFSS [high in fat, salt and sugar] foods and alcohol”
European Commission (2016), page 62.
Example 2: the General Food Law
The RSB opinion on the fitness check of the General Food Law in October 2017 clarifies how and where the simplification objectives were targeted. In a recommendation about efficiency and the potential for simplification, it states that:
“The report contains evidence in several places on efficiency and regulatory costs for businesses. As a REFIT [regulatory fitness programme] initiative, it should draw balanced conclusions from this evidence, particularly for SMEs [small and medium enterprises] and microenterprises, [sic] It could also strengthen its findings and conclusions on the potential to simplify the food safety acquis.”
Opinion of the Regulatory Scrutiny Board on the Fitness Check of the General Food Law
Example 3: the General Pharmaceutical Law
The RSB opinion on the impact assessment accompanying the revision of the General Pharmaceutical Law (GPL) in November 2022 acknowledges the low benefit-cost ratio of the proposals. It recommends that:
“The report should better compare the options, based on overall cost-benefit estimates for each option and each affected key group (including their presentation in consolidated comparison tables). It should be clear if a net positive benefit is expected as the preferred option shows a very low benefit-cost ratio.”
European Commission (2023) Annex 1, page 5.
Cases of industry engaging with Better Regulation
How engaged are commercial actors in the development of Better Regulation policy, and what do they call for? In the below, we gather together some examples of how industry actors continue to support, promote and lobby the Better Regulation framework, illustrating the importance that is assigned to this agenda and its relevance to our understanding of the commercial determinants of health.
Example 1: BusinessEurope
In January 2020, BusinessEurope published a strategy paper addressing the one-in-one-out approach. In it, the confederation expresses its support for embedding regulatory offsetting within the policy process, and argues that the ‘effectiveness’ of the approach will require that both administrative and compliance costs are included within it. It also reiterates its support for the wider Better Regulation framework and calls for stakeholder participation, noting that ‘the costs that are to be reduced should be those that are considered as most burdensome by stakeholders’, specifically referencing the value of the REFIT Platform for this purpose.
https://www.businesseurope.eu/publications/one-in-one-out-at-eu-level-businesseurope-strategy-paper/
Example 2: FoodDrinkEurope
In April 2021, FoodDrinkEurope issued a statement in support of the Commission’s latest communication on Better Regulation. As well as affirming that ‘FoodDrinkEurope remains committed to providing industry input in impact assessment processes, stakeholder consultations and other fora’, the statement mirrors Commission language in framing the various Better Regulation instruments as ‘key tools to translate evidence and stakeholder input into objective analysis supporting political decision-making’.
Example 3: Cefic
Responding to the Commission’s ‘stocktaking’ of Better Regulation in 2018, Cefic – the European Chemical Industry Council – published a position paper praising the progress made by the Juncker Commission. In particular, it focused on the Regulatory Scrutiny Baord’s efforts ‘to guide Commission Services towards compliance with better regulation guidelines and tools’, as well as the ‘evaluate first’ principle, and the publication of draft implementing and delegated acts for stakeholder feedback. It goes on to call for publication of all draft measures affecting chemicals stakeholders – including agency decisions – and for ‘more tangible burden reduction results’.
https://cefic.org/app/uploads/2019/02/Better-reguation-Stocktaking_BetterREgulation_PP-2018.pdf
Research Summaries
This section contains highlights from academic articles related to Better Regulation and health policy. We share the original articles alongside our summaries.
BRBH project resources
The Better Regulation for Better Health project produced different outputs and activities, including capacity building workshops, a report and recommendations on the consultation exercises, based on feedback from civil society organisations.
Capacity building workshops
View our overviews and highlights of four capacity-building workshops, which took place as part of the BRBH project.
Better regulation in practice: Policy briefs
Further reading
Additional resources used to inform the BRBH project.
Project Sources
- Better Regulation for Better Health project (2024). Available at: https://better-regulation-better-health.org/
- Better Regulation for Better Health project (2024). Between art and science: Policy-making for health in the EU. Available at: https://epha.org/between-art-and-science-policy-making-for-health-in-the-eu/
- EPHA – Better Regulation for Better Health project (2022). Available at: https://epha.org/campaigns/better-regulation-better-health/
- EPHA (2023c). “The revision of the Food Information to Consumers Regulation | Workshop Report”. Available at: https://epha.org/the-revision-of-the-food-information-to-consumers-regulationworkshop-report/
Other relevant toolkits for civil society and public health
- Civicus (2015) Advocacy Toolkit Influencing the Post-2015 Development Agenda. Available at: https://civicus.org/images/stories/SD2015%20Post-2015%20Advocacy%20Toolkit_FINAL.pdf
- CSO Lifeline (2022). Advocacy in Restricted Spaces: A Toolkit for Civil Society Organizations. Available at: https://www.csolifeline.org/advocacy-toolkit
- EnTrust (2024). Enlightened Trust: A Wiki for social and civic activism. Available at: https://entrust-wiki.eu/
- The Good Lobby (2024) Advocacy Pills. Available at: https://www.thegoodlobby.eu/2024-eu-elections/advocacy-pills/
- UNCA Coalition (2023) Civil Society Toolkit for the Conference of the States Parties to the United Nations Convention against Corruption. Available at: https://uncaccoalition.org/wp-content/uploads/COSP-CSO-Toolkit-Final.pdf
- WHO (2022). Toolkit for tackling misinformation on non-communicable diseases – Forum for tackling misinformation on health and NCDs. Available at: https://cadmus.eui.eu/bitstream/handle/1814/74972/WHO_Toolkit_for_tackling_misinformation_2022.pdf?sequence=1
Sources on Better Regulation
- Alemanno, A. (2015). “How Much Better is Better Regulation? Assessing the Impact of the Better Regulation Package on the European Union – A Research Agenda”. European Journal of Risk Regulation, 6(3), 344-356.
- BEUC (2015). “Better Regulation Watchdog”. Available at: https://www.beuc.eu/sites/default/files/publications/beuc-x-2015-047_upa_better_regulation_watchdog_founding_statement_and_members.pdf
- Brooks, E., Godziewski, C., & Deruelle, T. (2024). “The political determinants of health and the European Union”. Journal of Health Politics, Policy and Law, 49(5), 673–689. Article 11257064. https://doi. org/10.1215/03616878-11257064. Available at: https://www.research.ed.ac.uk/en/publications/thepolitical-determinants-of-health-and-the-european-union
- Brooks, E., & Lauber, K. (2024). Administering a chill pill? Better Regulation and the potential for regulatory chill in European Union health policy. Journal of Health Politics, Policy & Law. https://doi.org/10.1215/03616878-11257072
- Dunlop, C., & Radaelli, C. (2022). Better Regulation in the European Union. In M. D. M. Maggetti, F//Natalini, A. (Ed.), The Handbook of Regulatory Authorities (pp. 303-313). Edward Elgar.
- European Commission (2017). “Future of Europe white paper”. Available at: https://commission. europa.eu/publications/white-paper-future-europe_en
- European Commission (2021). “Better Regulation guidelines”. Available at: https://commission.europa.eu/document/download/d0bbd77f-bee5-4ee5-b5c4-6110c7605476_en?filename=swd2021_305_en.pdf
- European Commission (2021). “Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Better regulation: Joining forces to make better laws”. Available at: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=COM:2021:219:FIN
- European Commission (2024). “Better Regulation: why and how”. Available at: https://commission.europa.eu/law/law-making-process/planning-and-proposing-law/better-regulation_en
- European Commission (2024). “Better regulation toolbox”. Available: https://commission.europa.eu/law/law-making-process/planning-and-proposing-law/better-regulation/better-regulation-guidelinesand-toolbox_en
- European Ombudsman (2024). “Ombudsman asks Commission to ensure diversity of expertise on Regulatory Scrutiny Board”. Available at: https://www.ombudsman.europa.eu/en/news-document/en/192602
- Greer, S. L., Rozenblum, S., Fahy N., Panteli, D., Jarman, H., Brooks, E., de Ruijter, A., Rockwell, 45 O., Wismar; M. (2024). Everything you always wanted to know about European Union health policies but were afraid to ask. European Observatory on Health Systems and Policies. Available at: https://eurohealthobservatory.who.int/publications/i/everything-you-always-wanted-to-know-abouteuropean-union-health-policies-but-were-afraid-to-ask-fourth-revised
- Lauber, K., & Brooks, E. (2023). Why meta-regulation matters for public health: the case of the EU better regulation agenda. Globalization and Health, 19(1), 70. https://doi.org/10.1186/s12992-023-00971-4
- Laulom, S. (2018). Better regulation and the social acquis: Is the REFIT fit for purpose? European Labour Law Journal, 9(1), 7-23. https://doi.org/10.1177/2031952518756907
- OECD (2022). “Better Regulation Practices across the European Union 2022”. Available at: http://www.oecd.org/en/publications/2022/06/better-regulation-practices-across-the-european-union2022_51d00421.html
- Smith, K. E., Fooks, G., Collin, J., Weishaar, H., & Gilmore, A. (2010). Is the Increasing Policy Use of Impact Assessment in Europe Likely to Undermine Efforts to Achieve Healthy Public Policy? Journal of Epidemiology and Community Health, 64(6), 478-487. https://doi.org/10.1136/jech.2009.094300
Civic space and civil society participation
- EPHA (2021). “Sustainable financing of European non-governmental organizations”. Available at: https://epha.org/sustainable-financing-of-european-non-governmental-organizations
- EPHA (2023). “Enhancing Civic Space and Civil Society Participation in the Defence of Democracy Package”. Available at: https://epha.org/enhancing-civic-space-and-civil-society-participation-in-thedefence-of-democracy-package/
- EPHA (2023). “The critical importance of sustainable funding for health civil society”. Available at: https://epha.org/the-critical-importance-of-sustainable-funding-for-health-civil-society/
- EPHA (2024). “Health civil society engagement in a shrinking civic space”. Available at: https://epha.org/health-civil-society-engagement-in-a-shrinking-civic-space/
- EU4Health Civil Society Alliance (2022). “Towards meaningful engagement of health civil society organisations in EU public health policy-making — Joint Position Paper”. Available at: http://eu4health.eu/towards-meaningful-engagement-of-health-civil-society-organisations-in-eu-publichealth-policy-making-joint-position-paper/
- European Civic Forum (2023). “EU Civic Space Report 2023”. Available at: https://civic-forum.eu/civic-space-report-2023-fighting-for-democratic-empowerment-and-resilience
- European Civic Forum (2024). “EU Civic Space Report 2024”. Available at: https://civic-forum.eu/civic-space-report-2024
- European Parliament (2022). “Report on the shrinking space for civil society in Europe (2021/2103(INI))”. Available at: https://www.europarl.europa.eu/doceo/document/A-9-2022-0032_EN.html
Commercial Determinants of Health
- EPHA (2021). “Towards a childhood free from unhealthy food marketing”. Available at: https://epha.org/campaigns/regulate-food-marketing/
- EPHA (2021). “Blueprint for an EU Directive to protect children against the marketing of nutritionally poor food”. Available at: https://epha.org/wp-content/uploads/2021/11/blueprint-eu-directive-protectchildren-against-the-marketing-of-nutritionally-poor-food-final-november2021.pdf
- European Ombudsman (2024). “The European Commission’s refusal to give public access to documents concerning an impact assessment on the revision of the Food Information to Consumers Regulation”. Available at: https://www.ombudsman.europa.eu/en/case/en/65697?utm_source=%E2%80%8Bsome_EO&utm_medium=linkedin_organic&utm_campaign=Accesstodocs_Nutriscore
- Lauber, K., & Brooks, E. (2024). A missed opportunity for public health: How impact assessment shaped EU rules on the marketing of unhealthy commodities to children. Social Science & Medicine, Qualitative Research in Health, 5, 100369. https://doi.org/https://doi.org/10.1016/j.ssmqr.2023.100369
- Smith, K. E., Fooks, G., Gilmore, A. B., Collin, J., & Weishaar, H. (2015). Corporate Coalitions and Policy Making in the European Union: How and Why British American Tobacco Promoted ‘‘Better Regulation”. Journal of Health Politics, Policy & Law, 40(2), 325-372. https://doi.org/10.1215/03616878-2882231
- World Health Organization Regional Office for Europe (2024). “Commercial Determinants of Noncommunicable Diseases in the WHO European Region”. Available at: https://iris.who.int/ handle/10665/376957. License: CC BY-NC-SA 3.0 IGO
Stakeholder networks and portals
- Deregulation Watch: https://www.corporateeurope.org/en/2025/03/deregulation-watch
- EU Health Policy Platform: https://webgate.ec.europa.eu/hpf/
- Have your say: https://ec.europa.eu/info/law/better-regulation/
- Transparency Register: https://transparency-register.europa.eu/index_en
Acknowledgements
This toolkit was created as part of the Better Regulation for Better Health project. The project is led by Dr Eleanor Brooks, University of Edinburgh, and funded by UK Research and Innovation (Medical Research Council grant reference MR/T023244/1). The toolkit was compiled by Clémentine Richer-Delforge (European Public Health Alliance), Rebecca Barlow-Noone (European Public Health Alliance), and Eleanor Brooks, with assistance and contributions from Dr Kathrin Lauber (University of Edinburgh), Milka Sokolovic (European Public Health Alliance), Raymond Gemen (European Public Health Alliance), Alessandro Gallina (European Public Health Alliance), Frazer Goodwin (European Public Health Alliance) and Alba Gil (Association of European Cancer Leagues).
The toolkit was designed to engage with civil society actors and partners. If you’re involved in research, advocacy, policy-making or capacity-building on these issues, we’d love to hear from you!
Contact us at epha@epha.org, or contact Dr Eleanor Brooks directly.